Particulates in Biological products. Why test them and what are the new reporting requirements  
Date
Tue, Jan 31, 2012 at 10:00 am to 11:30 am PST
Palo Alto, CA
Date, Time and Location
Starting
Tue, Jan 31, 2012 at 10:00 AM PST
Ending
Tue, Jan 31, 2012 at 11:30 AM PST
Location & Address
Online Event
2600 E. Bayshore Road
Palo Alto, CA
United States-94303

Maps        Weather

Share with friends Share/tag this pageShare/tag this page
Add to My CalendarAdd to My Calendar
Register Now
Ticket Types Price
($)    
  Fee 
($)    
  Qty
Paid  (more) 299.00 5.98 USD 1 27078 299.00 5.98 Paid N/A 1
Sale Ended
Tue, Jan 31, 2012 at 10:00 am to 11:30 am
  
Event Details
Why Should You Attend:
Particulates in Biologics injectibles can arise from the aggregation of the protein product. It has been suggested that the aggregated material presents a safety concern because it increases the possibility of formation of anti drug antibodies. The FDA has therefore requested BLA sponsors to present sub-visible particulate data at the clinical and commercial stage and has identified the 0.2 - 10 micron as a range where there is a lack of suitable techniques for testing particles. Whether the aggregates in protein therapeutics truly increase the immunogenicity of the product is not completely clear and continues to be debated in the industry. Nevertheless this debate has increased the scrutiny of reviewers on the testing and reporting of particulates in Protein Therapeutics.
This webinar addresses recent discussions in the industry related to testing sub-visible particulates in Biologics injectibles. Recent FDA expectations for reporting data will be discussed. Methods for characterization and routine testing of particulates, their advantages and limitations will be discussed. Case studies where the various methods have been used for characterization of the sub-visible particles will be discussed.
Areas Covered in the Seminar:
Why test for sub-visible particulates in protein therapeutics.
Current expectations for testing for particulates in protein therapeutics.
USP method for particulate testing in injectibles.
Commonly used 'work-horse' methods for particulates: SEC and SDS-PAGE.
AUC and FFF.
Light scatter methods.
Imaging methods.
Electronmicroscopy.

For More Details:
http://complianceonline.com/ecommerce/control/trainingFocus/~product_id=701600?channel=eventsbot
Event Hosted By
ComplianceOnline
Get trained on regulations affecting your industry through online webinars, learn the best practices, and download quality standards, checklists and news articles. Listen to experts on best practices to streamline quality and compliance processes and meet the regulatory demands.
Contact the Organizer
eventsbot View other events hosted by ComplianceOnline
powered by
eventsbot Home
This web page was published using www.eventsbot.comOnline Event Registration and Management Service. If you have any issues/queries related to this event then please contact event organizer directly. You can also Register, Publish, Manage and Promote your events using eventsbot.
©2013 eventsbot. All rights reserved.